Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;65(8):601-609.
doi: 10.1111/ajd.14360. Epub 2024 Aug 8.

Dermatological care of gender-diverse patients in Australia

Roy Kingsley Wong  1 , Jenny Harrington  2 , Annabel Irene Stevenson  1   3   4
Affiliations
Review

Dermatological care of gender-diverse patients in Australia

Roy Kingsley Wong et al. Australas J Dermatol. 2024 Dec.

Abstract

In recent years, there has been an increasing recognition of the unique healthcare needs of gender-diverse patients in Australia. With the continuous growth of referrals to gender health services, there is an increased demand for specialised dermatological care. There is still a significant knowledge gap and a lack of guidelines specifically tailored to this patient group. In this article, we will provide a brief overview of the journey of Transgender and Gender Diverse (TGD) individuals as they embark on psychological and pharmacologic treatment for gender dysphoria in Australia. We endeavour to contribute to the existing body of knowledge by examining the evidence surrounding the treatment of skin, hair and nail issues for TGD patients. This article will outline how dermatologists can assist in the care of the gender-diverse patient. Although puberty blockade (stage 1 treatments) has minimal dermatological impact, gender-affirming pharmacotherapy (stage 2 treatments) can lead to many dermatological issues including acne, patterned hair loss (PHL) and dermatitis. The dermatologist may also play a role in stage 3 treatments which include surgical or procedural interventions for gender affirmation.

Keywords: Australia; cosmetic techniques; dermatology; sexual and gender minorities; skin diseases.

PubMed Disclaimer

Conflict of interest statement

We have no known conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
Gender‐diverse clinical pathway. Adapted from Telfer and The Royal Children's Hospital Melbourne Gender Service.,
FIGURE 2
FIGURE 2
Treatment of dermatological conditions in TGD Patients.
FIGURE 3
FIGURE 3
Comparison of feminine and masculine features with sites for neurotoxin injection and fillers. Adapted from Dhingra.
See this image and copyright information in PMC

References

    1. Telfer MM, Tollit MA, Pace CC, Pang KC. Australian standards of care and treatment guidelines for transgender and gender diverse children and adolescents. Med J Aus. 2018;209(3):132–136. - PubMed
    1. Cheung AS, Ooi O, Leemaqz S, Cundill P, Silberstein N, Bretherton I, et al. Sociodemographic and clinical characteristics of transgender adults in Australia. Transgender Health. 2018;3(1):229–238. - PMC - PubMed
    1. Coleman E. Standards of Care for the Health of transsexual, transgender, and gender‐nonconforming people. Standards of care for the health of transsexual, transgender, and gender‐nonconforming people: an introduction. Principles of gender‐specific medicine: Elsevier; 2017. p. 69–75.
    1. Mahfouda S, Moore JK, Siafarikas A, Zepf FD, Lin A. Puberty suppression in transgender children and adolescents. Lancet Diabetes Endocrino. 2017;5(10):816–826. - PubMed
    1. Bretherton I, Thrower E, Zwickl S, Wong A, Chetcuti D, Grossmann M, et al. The health and well‐being of transgender Australians: a national community survey. LGBT Health. 2021;8(1):42–49. - PMC - PubMed

LinkOut - more resources